首页> 外文期刊>International Journal of Advanced Robotic Systems >Development of Biomedical Microrobot for Intravascular Therapy
【24h】

Development of Biomedical Microrobot for Intravascular Therapy

机译:生物医学微管术治疗血管内疗法

获取原文
获取原文并翻译 | 示例
           

摘要

Recently, coronary artery disease such as angina pectoris and myocardial infarction has become the major causes of death. As a method of medical treatment for the disease, the pharmacological approaches and the surgical operations are executed. Especially, percutaneous coronary intervention (PCI) using catheters are the mostly preferred treatment for coronary artery diseases. The PCI technologies are advanced and the various useful devices are developed and utilized. However, some clinical operations such as the treatment of chronic total occlusion (CTO) remain a limitation of PCI and a major challenge. As robot-assisted coronary interventions, this paper proposes the microrobot for the therapy of CTO. The microrobot consists of the functions of position recognition, locomotion and treatment in the blood vessels. The functions of the microrobot can be validated through in-vitro & in-vivo experiments. The innovative technologies and surgical concept using the microrobot are currently being developed.
机译:最近,冠状动脉疾病如心绞痛和心肌梗塞已成为死亡的主要原因。作为疾病的医学治疗方法,执行药理学方法和外科手术。特别是,使用导管的经皮冠状动脉干预(PCI)是冠状动脉疾病的主要优选治疗。 PCI技术是先进的,并且开发和使用各种有用的设备。然而,一些临床操作,例如慢性总阻塞(CTO)的治疗仍然是PCI和主要挑战的限制。作为机器人辅助冠状动脉干预,本文提出了CTO治疗的微动虫间​​。微毒物由血管中位置识别,运动和治疗的功能组成。微毒物的功能可以通过体外和体内实验进行验证。目前正在开发使用MicroObot的创新技术和手术概念。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号